Supplementary Table 8 from Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study

Pamela Munster, Nicholas Iannotti, Daniel C. Cho,John M. Kirkwood, Liza C. Villaruz,Geoffrey T. Gibney,F. Stephen Hodi, Niharika B. Mettu, Mark Jones,Jill Bowman, Michael Smith,Mani Lakshminarayanan, Steven O'Day

crossref(2023)

Cited 0|Views0
No score
Abstract
Supplementary Table 8. Summary of steady state itacitinib pharmacokinetic parameters (cycle 2 day 1).
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined